-
I am a clinician. How do I join the RGCC Network?
We are proud to connect with healthcare professionals who are as passionate as we are about increasing understanding of cancer care and improving outcomes for cancer patients. To find out how you can connect with the RGCC Network, please contact our head office.
-
Which couriers can I use to send samples to RGCC?
We have a partnership with DHL, FEDEX and TNT.
-
Can I see a sample test report?
You can find example test reports on our website.
-
Where is RGCC based?
RGCC’s headquarters are in Switzerland. We have laboratory facilities in Greece, Germany and India. We work with a global network of healthcare providers across Europe, the USA and the rest of the world to offer our tests. We currently operate in 23 countries but are expanding our network.
-
Where will my test be performed?
Blood samples will be analysed in one of our three facilities, in Greece, Germany or India. We are unable to tell you where your test will be processed. Our laboratories work to the highest standards and process tests in exactly the same way to ensure their validity.
-
What else does RGCC do?
RGCC is at the forefront of personalised genetic testing for cancer. Alongside this, we are actively involved in pharmaceutical research and development working from our world-leading facilities in Europe. Our scientists regularly publish peer-reviewed research and are respected across the world.
-
Can I speak to someone at RGCC?
Yes. You can use our online contact form, or visit our contact page where you can find ways to get in touch with us.
-
What does RGCC stand for?
RGCC stands for Research Genetics Cancer Center. We prefer RGCC.
-
Where does the information in your news feed come from?
We regularly produce news stories about the latest developments in cancer diagnosis, tests and treatments and share these on our website.
-
I’ve been diagnosed with cancer, where should I go for information?
Every person and patient is unique, so we recommend that you speak to a clinician if you have any questions about cancer diagnosis, tests and treatments. You can book a consultation with an RGCC Network clinician by contacting us directly.
-
Which cancer cells do you test in an RGCC test?
In any tumour there are several subpopulations of cancer cells, but we only harvest and analyse cells with the tumour-initiating properties.
-
How are the Onconomics Plus and ChemoSNiP tests different?
The Onconomics Plus test provides information about the sensitivity or resistance of specific anti-cancer drugs, targeted therapies and natural treatments on the cancer cells in an individual patient. The ChemoSNiP test can be used to predict whether a patient will respond to drugs and metabolise them properly.
